Strategic plan to accelerate Australian drug development

November 18, 2005

Contract research organisation TetraQ has formed a strategic alliance with Ground Zero Pharmaceuticals Inc (GZP) to help new Australian pharmaceuticals get to market.

While only established in May [2005], The University of Queensland (UQ) based TetraQ is quickly becoming a key provider of services for Australian drug development companies.

US regulatory approval is a critical issue for Australian companies and the Food and Drug Administration (FDA) is unforgiving of mistakes in the preclinical development stage TetraQ Business Development Manager Dr Stuart Behncken said.

"Australian drug development companies targeting the US market are often unaware of the issues they can encounter with the FDA, and they find that they also need help preparing the complex documentation," Dr Behncken said.

"The Californian-based GZP is perfect for assisting our clients because they provide advice on the drug development process and prepare regulatory submissions to the FDA."

In five months of operations, the organisation has conducted 36 pre-clinical studies for 15 Australian clients, including four ASX listed companies.

Formed by four leading UQ researchers and operating through UQ's main commercialisation company UniQuest Pty Ltd, TetraQ was designed to provide a "one-stop-shop" for pre-clinical drug development in Australia.

Australia's pre-clinical drug development capability is limited or fragmented, so most Australian companies contract the bulk of their pre-clinical drug development work overseas, according to Dr Behncken.

"It's TetraQ's mission to retain as much of this work in Australia as possible, as well as to give the extra advice and interpretation that is often lacking with the larger providers," he said.

"As we roll out additional TetraQ's services in all four areas of pre-clinical research, we expect to become a stronger alternative to the overseas organisations, but in the meantime will continue to provide value-added services to clients."

In the next six months, an $8.1 million grant from the Queensland State Government will be used to expand TetraQ's capability with the refurbishment of laboratory facilities fitted with state-of-the-art equipment.

In 2006, TetraQ will seek Good Lab Practice (GLP) accreditation, making it one of the few Australian groups qualified to perform toxicology services for clients that meet the requirements of regulators in the USA and Europe.
Media inquiries: Dr Stuart Behncken at TetraQ 61-733-469-933,About TetraQ

Based at The University of Queensland in Brisbane, TetraQ is the first contract research organisation in Australia to provide integrated pre-clinical services to the global pharmaceutical and biotechnology industries. TetraQ provides specialist services and advice to companies who are in the early stages of drug development and can assist in bridging the gap between drug discovery early stage clinical trials. Services include efficacy assessment, ADME (absorption, distribution, metabolism and elimination) profiling, toxicology assessment and pharmaceutics profiling, including preclinical drug formulation.

About Ground Zero Pharmaceuticals

Based in Irvine, a major centre of pharmaceutical and biotechnology innovation in Southern California, Ground Zero Pharmaceuticals Inc is a regulatory affairs and product development consulting firm providing strategic and tactical support to the pharmaceutical, biologics, biotechnology and medical device industries. Its service portfolio includes regulatory representation and submissions, strategic medical strategy, preclinical planning and data assessment, medical writing, manufacturing controls compliance, clinical assessment, data management, clinical monitoring, biostatics, and project management.

Research Australia

Related Pharmaceuticals Articles from Brightsurf:

A plot twist in pharmaceuticals: Single nanoparticles could pave the way for medicines on demand
For the first time, a single, twisted nanoparticle has been accurately measured and characterised in a lab, taking scientists one vital step closer to a time when medicines will be produced and blended on a microscopic scale.

New pharmaceuticals: public research combines efficiency with contained costs
Is the basic research that goes into the development of new drugs more efficiently conducted by public-sector scientists, pharmaceutical firms, or independent private laboratories?

New STM technique points way to new and purer pharmaceuticals
A research project led by chemists at the University of Warwick first used ultrahigh resolution scanning tunnelling microscopy to see the exact location of atoms and bonds within a molecule, and then employed these incredibly precise images to determine the interactions that bond molecules to one another.

Study describes cocktail of pharmaceuticals in waters in Bangladesh
An analysis revealed that water samples held a cocktail of pharmaceuticals and other compounds, including antibiotics, antifungals, anticonvulsants, anesthetics, antihypertensive drugs, pesticides, flame retardants and more.

Treating wastewater with ozone could convert pharmaceuticals into toxic compounds
With water scarcity intensifying, wastewater treatment and reuse are gaining popularity.

Study calls for improved sanitation and the environmental management of pharmaceuticals
Failure to ensure the environmental sustainability of growing patient access to medicines in developing economies could increase the risk of adverse environmental impacts, according to new research led by the University of Plymouth.

Chemicals for pharmaceuticals could be made cheaper and greener by new catalysts
High value chemicals used to make pharmaceuticals could be made much cheaper and quicker thanks to a series of new catalysts made by scientists at the University of Warwick in collaboration with GoldenKeys High-Tech Co., Ltd. in China.

Soaking up pharmaceuticals and personal care products from water
Medications excreted in the urine or dumped into the toilet can end up in the water supply, just like lotions or cosmetics that wash off the body and go down the sink or shower drain.

New study finds river wildlife contain cocaine, pharmaceuticals and pesticides
For the first time, researchers at King's College London, in collaboration with the University of Suffolk, have found a diverse array of chemicals, including illicit drugs and pesticides in UK river wildlife.

Metal-free catalyst to convert aldehyde into ketone, a basic structure of pharmaceuticals
We succeeded in synthesizing a ketone, a basic structure of many pharmaceuticals, from an aldehyde and a carboxylic acid using N-heterocyclic carbene catalyst under mild conditions.

Read More: Pharmaceuticals News and Pharmaceuticals Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to